Zambeli-Ljepovic, A., Wang, F., Hyslop, T., Roman, S. A., Sosa, J. A., & Scheri, R. P. (2018). Total Thyroidectomy and Radioactive Iodine for Elderly Patients with Low-Risk Papillary Thyroid Cancer Confers No Survival Benefit over Lobectomy Alone. In Journal of the American College of Surgeons (Vol. 227, pp. S88–S89). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/j.jamcollsurg.2018.07.176

Zambeli-Ljepovic, Alan, Frances Wang, Terry Hyslop, Sanziana A. Roman, Julie A. Sosa, and Randall P. Scheri. “Total Thyroidectomy and Radioactive Iodine for Elderly Patients with Low-Risk Papillary Thyroid Cancer Confers No Survival Benefit over Lobectomy Alone.” In Journal of the American College of Surgeons, 227:S88–89. Ovid Technologies (Wolters Kluwer Health), 2018. https://doi.org/10.1016/j.jamcollsurg.2018.07.176.

Zambeli-Ljepovic A, Wang F, Hyslop T, Roman SA, Sosa JA, Scheri RP. Total Thyroidectomy and Radioactive Iodine for Elderly Patients with Low-Risk Papillary Thyroid Cancer Confers No Survival Benefit over Lobectomy Alone. In: Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2018. p. S88–9.

Zambeli-Ljepovic, Alan, et al. “Total Thyroidectomy and Radioactive Iodine for Elderly Patients with Low-Risk Papillary Thyroid Cancer Confers No Survival Benefit over Lobectomy Alone.” Journal of the American College of Surgeons, vol. 227, no. 4, Ovid Technologies (Wolters Kluwer Health), 2018, pp. S88–89. Crossref, doi:10.1016/j.jamcollsurg.2018.07.176.

Zambeli-Ljepovic A, Wang F, Hyslop T, Roman SA, Sosa JA, Scheri RP. Total Thyroidectomy and Radioactive Iodine for Elderly Patients with Low-Risk Papillary Thyroid Cancer Confers No Survival Benefit over Lobectomy Alone. Journal of the American College of Surgeons. Ovid Technologies (Wolters Kluwer Health); 2018. p. S88–S89.